LONE TREE, Colo., Jan. 8, 2026 /PRNewswire/ -- Cochlear, the global leader in implantable hearing solutions, is proud to announce that the groundbreaking Nucleus® Nexa® System is now available to ...

LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...

Hearing is one of those things most people never think about until it’s gone. For millions living with severe to profound hearing loss, a cochlear implant isn’t just a device. It’s a way back to ...

Cochlear Ltd. heard good news from the U.S. FDA, as the agency approved its next-generation cochlear implant, the Nucleus Nexa System, the first smart cochlear implant system. Cochlear expects to ...

Six months after becoming the first patient in the United States to receive a newly FDA-approved cochlear implant system, 18-month-old Nene Gudavadze is responding to sound, dancing to music, and ...

Apollo Children’s Hospitals, Chennai has successfully performed Tamil Nadu’s First Cochlear™️ Nucleus®️ Nexa™️ implant surgery, marking a significant milestone (on World Hearing Day 3 March) in ...

Cochlear downgraded fiscal 2025 NPAT guidance by 6% at the midpoint to AUD 390 million-AUD 400 million. Services revenue declined more than expected and cochlear implant sales in developed markets ...

The Cochlear Ltd (ASX: COH) share price is in focus today after the company reported FY25 sales revenue up 4% to $2,356 million and a 9% jump in statutory net profit to $389 million, with a 5% ...